Searched for
ABBOTT LABS
Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...- Abbott Labs to face trial on infant formulaA Chicago trial begins Wednesday. Four families claim Abbott Laboratories' baby formula caused a dangerous bowel disease in their premature...
- Abbott in talks to buy exact sciences as cologuard maker’s shares jumpAbbott Laboratories is in talks to buy Exact Sciences, a company known for its Cologuard cancer test. Reports say the possible deal is in a...
- Radcliffe Labs aims to scale up operations; go public in 2025-26He noted that the majority of the expansion will be in Tier II, Tier III and Tier IV locations across states like Uttar Pradesh, Madhya Pra...
- FDA approves 15 minute, five dollar coronavirus test that doesn't need specialty equipmentThe 15-minute test from Abbott Laboratories will sell for $5, giving it a competitive edge over similar tests that need to be popped into a...
- 'Enhance testing capacity and get states to ease process of registering phlebotomists'A governmental panel dealing with Covid-19 testing and surveillance has asked the health ministry to enhance testing capacity and get state...
- P&G catches cold as Vicks goes off the shelf; Pfizer, Abbott in pain tooCompanies such as Abbott India, Macleods Pharma, Pfizer, Alkem Labs and IPCA Labs are among the companies that are likely to be hurt by the...
- Abbott Labs up 100% in 15 months, still not expensive: Mehraboon IraniLooking at the numbers, which the management was talking about, the stock still does not look very expensive, says Irani.
- We have strong products, but corporate brand really counts: Paul Magill, Senior VP, Abbott Labs"There are two different layers of branding -the product layer and then the corporate layer. We always had very strong brands," says Paul.
- Midcap Mantra: Abbott holds a very promising prospect, hopes to sustain growthThe company enjoys strong brand equity in multiple therapeutic categories with seven of its top ten brands commanding leadership positions ...
- Strides Arcolab sells drug injectible business for Rs 9000 crore to MylanThe purchase values Agila at 18.7 times December 2012 operating profit of $86 million and seven times its sales of $255 million.
- Indo-US body's job fair attracts major cos like IBM, Infosys and Abbott LabsRecruiters from over 40 major companies, including IBM, Infosys and Abbott Labs, took part in a job fair organised by Indo-American Communi...
- Abbott Labs partners Biocon to develop nutrition products for IndiaAbbott Laboratories has partnered biotechnology company Biocon Ltd to develop nutrition products for India.
- Would like to buy small stakes in various low-risk companies, says Ajay PiramalAt a time when market is volatile and confusing, Ajay Piramal thinks to buy small stakes in various companies, which are low-risk, generate...
- Piramal charts global acquisition plan to grow contract research bizPiramal Healthcare will persist with its tested growth strategy of acquisitions to be counted among the world’s top five contract manufactu...
- Small drug cos on anti-buyout driveConcerned about the recent spate of takeovers of domestic pharma firms by MNCs, small and medium players in the sector have decided to appr...
- Meet Mr. Right Timing: Ajay PiramalIn terms of valuation, Abbott purchase of Piramal's healthcare unit is far ambitious than Daiichi Sankyo’s purchase of Ranbaxy. Full covera...
- Investors lap up Dishman shares as Solvay-Abbott strike dealDishman Pharmaceuticals is likely to be in the pink of health after its Belgian client Solvay Group has been taken over by US drug-maker Ab...
- Lupin reaches out-of-court settlement with Abbott on OmnicefDomestic pharma company Lupin has reached an out-of-court settlement with US pharma major Abbott and Japan’s Astellas Pharma for the market...
- Wockhardt challenges patents litigationWockhardt Pharma has just got into the game. The co is challenging Abbott Lab patent on epilepsy drug.
Load More
